AIG IBD Summit 2023 is an international event organized by the AIG Hospitals. This year the Summit was held between 7th to 9th April at HICC, Hyderabad.
This event brought together top gastroenterologists, leading researchers, and industry experts and there were great discussions on the latest advances in Inflammatory bowel disease (IBD).
Inflammatory Bowel disease includes Crohn’s Disease & Ulcerative Colitis that are chronic lifelong conditions. Establishing and maintaining symptom control & remission is critical to minimize complications. IBD is an emergent disease not only in India but in several parts of the Asia-Pacific, Africa, and the Middle East with a rising incidence over the last decade. The changing socioeconomic environment and prevalent disease patterns has presented unique diagnostic dilemmas, management controversies and challenges. Key international and national experts in the field discussed, debated, and highlighted the latest concepts and consensus in the management of IBD. Team Gastrocare participated with great enthusiasm & there were lot of discussions held with PAN-India Doctors on our complete Gastrocare range of products & our dedicated Patient-Support ventures.
Our unique advanced colon release technology for Mesarem (Mesalamine Tablets) was appreciated by maximum Doctors who attended the stall. We also highlighted India’s first adalimumab auto injector our Mabura which ensures Technology for Convenience and better Patient compliance. We also got an opportunity to celebrate Easter with a couple of Doctors on 9th April’23 & Doctors whole-heartedly appreciated Hetero Healthcare’s continuous support in their IBD Patient care journey. The Summit witnessed 1000+ Delegates across the world and it was eventful conference.
The Hetero Healthcare - Gastrocare Division proudly participated in the AIG Liver Conclave 2025 at HICC, Novotel, Hyderabad, held on September 26-27.
PatchMantra - A Patch. A Mantra. A Better Way to Heal A revolutionary platform bringing patch therapy to the forefront of modern healthcare.
Hetero Healthcare Ltd., one of India’s leading pharmaceutical companies, has launched Perzea, the most affordable biosimilar of Pertuzumab, in collaboration with Enzene Biosciences Ltd.
At Hetero Healthcare, we believe true loyalty deserves more than applause-it deserves horsepower.
At Hetero Healthcare, we believe loyalty isn’t just about meeting numbers-it’s about trust, commitment, and enduring partnerships.
We are delighted to announce the expansion of KRIS PLUS – Hetero Healthcare into Uttar Pradesh, marking a significant step beyond our initial presence in the West zone and into new and promising territory.
The spotlight was on. The energy? Unmatched.
At the heart of Vijayawada, from July 11-13, our Volga Division from Hetero Healthcare became part of something bigger-SZUSICON 25-26, a space where knowledge flowed, ideas took root, and partnerships blossomed.
We are proud to announce the launch of our newest division - KRIS PLUS, an ambitious initiative aimed at deepening market reach and enhancing our engagement with healthcare professionals and patients alike.
The Speciality Care Division of Hetero Healthcare had the privilege of participating in the Hyderabad Intensive Care Symposium, held from June 19–22, 2025, at Sindhu Hospitals, Hitec City.
Your email address & phone will not be published. Required fields are marked *
Copyright ©2025 All Rights Reserved by Hetero Healthcare Limited.